COVID-19: big pharma confident on supply chain integrity
As the novel coronavirus continues to spread across countries, concern about the potential for disruption to the manufacture and distribution...
GenSight Biologics announces presentation of bilateral visual recovery from GS010 Phase III trials
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for...
J&J’s Experimental Lung Cancer Drug Receives Breakthrough Therapy Designation
The Janssen Pharmaceutical, a Johnson & Johnson company, reported the U.S. Food and Drug Administration (FDA) granted its JNJ-6372 Breakthrough...
Silverback Therapeutics Raises $78.5 Million to Advance Cancer Antibody Conjugates for Solid Tumors
Silverback Therapeutics, headquartered in Seattle, closed on an oversubscribed Series B financing round worth $78.5 million. It was led by...
Regeneron and Sanofi Aim a Rheumatoid Arthritis Drug at Coronavirus
Could an arthritis medication show promise as a treatment for the symptoms related to the coronavirus? That’s what Regeneron and...
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and...
New Multi-Instrument Calibrator Designed to Improve Accuracy and Save Time for Leak Detection and Repair Compliance
For refineries and petrochemical plants, a new multi-instrument calibrator is designed to save time and improve accuracy of daily calibrations...
Recipharm supports FDA approval of Perrigos AB-rated generic product
Recipharm, a leading contract development and manufacturing organisation (CDMO), is pleased to note the FDA’s approval of Perrigo’s AB-rated generic...
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development...
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.